设为首页 电子邮箱 联系我们

本刊最新招聘信息请见“通知公告”!  本刊投稿系统试运行中,欢迎投稿!如投稿有问题,可直接将稿件发送至zgyy8888@163.com

 

主管单位:中华人民共和国   

国家卫生健康委员会

主办单位:中国医师协会
总编辑:
杨秋

副总编辑:魏永祥、张运、

罗毅、谭学瑞、唐来坤、

王喜艳

编辑部主任:杨秋

邮发代号:80-528
定价:20.00元
全年:240.00元
Email:zgyy8888@163.com
电话(传真):010-64428528;
010-64456116(总编室)

                  

过刊目录

2021 年第 9 期 第 16 卷

亚临床甲状腺功能减退症对射血分数降低型急性心力衰竭患者预后的预测价值

Predictive value of subclinical hypothyroidism in progrosis of patients with acute heart failure with reduced ejection fraction

作者:张倩王春梅张慧敏王喜福高海郭畅姚威 聂绍平

英文作者:Zhang Qian Wang Chunmei Zhang Huimin Wang Xifu Gao Hai Guo Chang Yao Wei Nie Shaoping

单位:首都医科大学附属北京安贞医院冠心病中心100029

英文单位:Coronary Heart Disease Center Beijing Anzhen Hospital Capital Medical University Beijing 100029 China

关键词:急性心力衰竭;亚临床甲状腺功能减低;预后

英文关键词:Acuteheartfailure;Subclinicalhypothyroidism;Progrosis

  • 摘要:
  • 目的 探讨亚临床甲状腺功能减退症(SCH)对射血分数降低型急性心力衰竭(AHF)患者预后的预测价值。方法 回顾性分析20161月至201812月在首都医科大学附属北京安贞医院急诊住院的射血分数降低型AHF患者1 573例。根据入院时的促甲状腺激素水平将患者分为SCH(105)和无SCH(1 468)。比较2组患者一般资料、30 d再住院率、1年全因死亡率以及2年全因死亡率,分析患者随访2年全因死亡的危险因素。结果 SCH组入院时收缩压及B型脑钠肽(BNP)水平高于无SCH组[(133±28mmHg1 mmHg=0.133 kPa)比(130±26mmHg1 982(1 195,2 644)ng/L1 731(1 061,2 565)ng/L],住院时间长于无SCH组[(8.6±3.3d比(7.4±2.8d(P0.05)SCH组患者30 d再住院率和1年全因死亡率以及2年全因死亡率均高于无SCH组患者[41.9%44/105)比28.3%416/1 468)、37.1%39/105)比26.2%385/1 468)、52.4%55/105)比41.5%609/1 468)],差异均有统计学意义(均P0.05)。多因素Cox回归模型分析结果显示,SCH是射血分数降低型AHF患者随访2年全因死亡的独立危险因素(风险比=1.5395%置信区间:1.082.21P=0.018),同时年龄(风险比=2.6495%置信区间:1.674.15P0.001)、入院BNP水平(风险比=1.8395%置信区间:1.172.76P=0.002)也是患者随访2年全因死亡的独立危险因素。结论 SCH是射血分数降低型AHF患者随访2年全因死亡的独立危险因素。

  • Objective To explore the predictive value of subclinical hypothyroidism (SCH) in prognosis of patients with acute heart failure (AHF) with reduced ejection fraction. Methods A total of 1 573 patients with AHF with reduced ejection fraction admitted to Beijing Anzhen Hospital, Capital Medical University from January 2016 to December 2018 were retrospectively analyzed. The patients were divided into SCH group (105 cases) and non SCH group (1 468 cases) according to the level of thyroid stimulating hormone on admission. General data, 30 d readmission rate, 1 year all-cause mortality and 2 years all-cause mortality were compared between the two groups, and the risk factors of all-cause death were analyzed during 2 years of follow-up. Results The systolic blood pressure and brain natriuretic peptide(BNP) levels on admission in SCH group were higher than those in non SCH group[(133±28mmHg vs 130±26mmHg, 1 982(1 195,2 644)ng/L vs 1 731(1 061,2 565)ng/L, and the length of stay in SCH group was longer than that in non SCH group [(8.6±3.3d vs 7.4±2.8d (all P0.05). The 30 d readmission rate, 1 year all-cause mortality and 2 years all-cause mortality in SCH group were higher than those in non SCH group41.9%44/105 vs 28.3%416/1 468, 37.1%39/105 vs 26.2%385/1 468, 52.4%55/105 vs 41.5%609/1 468)](all P0.05). Multivariate Cox regression analysis showed that SCH was an independent risk factor for 2 years all-cause death during the follow-up period in AHF patients with reduced ejection fraction (hazard ratio=1.53, 95% confidence interval: 1.08-2.21, P=0.018). Age (hazard ratio=2.64, 95% confidence interval: 1.67-4.15, P0.001) and BNP level on admission (hazard ratio=1.83, 95% confidence interval: 1.17-2.76, P=0.002) were also independent risk factors for 2 years all-cause death during the follow-up period. Conclusion SCH is an independent risk factor for 2 years all-cause death during follow-up period in patients with AHF with reduced ejection fraction.

copyright 《中国医药》杂志编辑部
地址:北京市朝阳区安贞路2号首都医科大学附属北京安贞医院北楼二层
电话:010-64456116 传真:010-64428528 邮编:100029 Email: zgyy8888@163.com
网址:www.chinamedicinej.com 京ICP备2020043099号-3
本系统由北京博思汇文数字科技有限公司设计开发 技术服务电话:400-921-9838
当您在使用本网站投稿遇到困难时,请直接将稿件投送到编辑部邮箱zgyy8888@163.com。







安卓


苹果

关闭